Copyright Reports & Markets. All rights reserved.

Global Somatostatin Receptor Type 2 Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Somatostatin Receptor Type 2 Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Somatostatin Receptor Type 2 Market Size Growth Rate by Product
      • 1.4.2 CRN-00808
      • 1.4.3 Lanreotide Acetate
      • 1.4.4 PRL-2903
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Somatostatin Receptor Type 2 Market Size Growth Rate by End User
      • 1.5.2 Hormonal Disorder
      • 1.5.3 Oncology
      • 1.5.4 Metabolic Disorder
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Somatostatin Receptor Type 2 Market Size
      • 2.1.1 Global Somatostatin Receptor Type 2 Revenue 2014-2025
      • 2.1.2 Global Somatostatin Receptor Type 2 Sales 2014-2025
    • 2.2 Somatostatin Receptor Type 2 Growth Rate by Regions
      • 2.2.1 Global Somatostatin Receptor Type 2 Sales by Regions
      • 2.2.2 Global Somatostatin Receptor Type 2 Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Somatostatin Receptor Type 2 Sales by Manufacturers
      • 3.1.1 Somatostatin Receptor Type 2 Sales by Manufacturers
      • 3.1.2 Somatostatin Receptor Type 2 Sales Market Share by Manufacturers
      • 3.1.3 Global Somatostatin Receptor Type 2 Market Concentration Ratio (CR5 and HHI)
    • 3.2 Somatostatin Receptor Type 2 Revenue by Manufacturers
      • 3.2.1 Somatostatin Receptor Type 2 Revenue by Manufacturers (2014-2019)
      • 3.2.2 Somatostatin Receptor Type 2 Revenue Share by Manufacturers (2014-2019)
    • 3.3 Somatostatin Receptor Type 2 Price by Manufacturers
    • 3.4 Somatostatin Receptor Type 2 Manufacturing Base Distribution, Product Types
      • 3.4.1 Somatostatin Receptor Type 2 Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Somatostatin Receptor Type 2 Product Type
      • 3.4.3 Date of International Manufacturers Enter into Somatostatin Receptor Type 2 Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Somatostatin Receptor Type 2 Sales by Product
    • 4.2 Global Somatostatin Receptor Type 2 Revenue by Product
    • 4.3 Somatostatin Receptor Type 2 Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Somatostatin Receptor Type 2 Breakdown Data by End User

    6 North America

    • 6.1 North America Somatostatin Receptor Type 2 by Countries
      • 6.1.1 North America Somatostatin Receptor Type 2 Sales by Countries
      • 6.1.2 North America Somatostatin Receptor Type 2 Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Somatostatin Receptor Type 2 by Product
    • 6.3 North America Somatostatin Receptor Type 2 by End User

    7 Europe

    • 7.1 Europe Somatostatin Receptor Type 2 by Countries
      • 7.1.1 Europe Somatostatin Receptor Type 2 Sales by Countries
      • 7.1.2 Europe Somatostatin Receptor Type 2 Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Somatostatin Receptor Type 2 by Product
    • 7.3 Europe Somatostatin Receptor Type 2 by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Somatostatin Receptor Type 2 by Countries
      • 8.1.1 Asia Pacific Somatostatin Receptor Type 2 Sales by Countries
      • 8.1.2 Asia Pacific Somatostatin Receptor Type 2 Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Somatostatin Receptor Type 2 by Product
    • 8.3 Asia Pacific Somatostatin Receptor Type 2 by End User

    9 Central & South America

    • 9.1 Central & South America Somatostatin Receptor Type 2 by Countries
      • 9.1.1 Central & South America Somatostatin Receptor Type 2 Sales by Countries
      • 9.1.2 Central & South America Somatostatin Receptor Type 2 Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Somatostatin Receptor Type 2 by Product
    • 9.3 Central & South America Somatostatin Receptor Type 2 by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Somatostatin Receptor Type 2 by Countries
      • 10.1.1 Middle East and Africa Somatostatin Receptor Type 2 Sales by Countries
      • 10.1.2 Middle East and Africa Somatostatin Receptor Type 2 Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Somatostatin Receptor Type 2 by Product
    • 10.3 Middle East and Africa Somatostatin Receptor Type 2 by End User

    11 Company Profiles

    • 11.1 Amryt Pharma plc
      • 11.1.1 Amryt Pharma plc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Amryt Pharma plc Somatostatin Receptor Type 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Amryt Pharma plc Somatostatin Receptor Type 2 Products Offered
      • 11.1.5 Amryt Pharma plc Recent Development
    • 11.2 Crinetics Pharmaceuticals Inc
      • 11.2.1 Crinetics Pharmaceuticals Inc Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Products Offered
      • 11.2.5 Crinetics Pharmaceuticals Inc Recent Development
    • 11.3 Daewoong Pharmaceutical Co Ltd
      • 11.3.1 Daewoong Pharmaceutical Co Ltd Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Products Offered
      • 11.3.5 Daewoong Pharmaceutical Co Ltd Recent Development
    • 11.4 Ipsen SA
      • 11.4.1 Ipsen SA Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Ipsen SA Somatostatin Receptor Type 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Ipsen SA Somatostatin Receptor Type 2 Products Offered
      • 11.4.5 Ipsen SA Recent Development
    • 11.5 Progenics Pharmaceuticals Inc
      • 11.5.1 Progenics Pharmaceuticals Inc Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Products Offered
      • 11.5.5 Progenics Pharmaceuticals Inc Recent Development
    • 11.6 Strongbridge Biopharma plc
      • 11.6.1 Strongbridge Biopharma plc Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Products Offered
      • 11.6.5 Strongbridge Biopharma plc Recent Development
    • 11.7 Zucara Therapeutics Inc
      • 11.7.1 Zucara Therapeutics Inc Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Products Offered
      • 11.7.5 Zucara Therapeutics Inc Recent Development

    12 Future Forecast

    • 12.1 Somatostatin Receptor Type 2 Market Forecast by Regions
      • 12.1.1 Global Somatostatin Receptor Type 2 Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Somatostatin Receptor Type 2 Revenue Forecast by Regions 2019-2025
    • 12.2 Somatostatin Receptor Type 2 Market Forecast by Product
      • 12.2.1 Global Somatostatin Receptor Type 2 Sales Forecast by Product 2019-2025
      • 12.2.2 Global Somatostatin Receptor Type 2 Revenue Forecast by Product 2019-2025
    • 12.3 Somatostatin Receptor Type 2 Market Forecast by End User
    • 12.4 North America Somatostatin Receptor Type 2 Forecast
    • 12.5 Europe Somatostatin Receptor Type 2 Forecast
    • 12.6 Asia Pacific Somatostatin Receptor Type 2 Forecast
    • 12.7 Central & South America Somatostatin Receptor Type 2 Forecast
    • 12.8 Middle East and Africa Somatostatin Receptor Type 2 Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Somatostatin Receptor Type 2 Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Somatostatin Receptor Type 2 market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Somatostatin Receptor Type 2 market based on company, product type, end user and key regions.

      This report studies the global market size of Somatostatin Receptor Type 2 in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Somatostatin Receptor Type 2 in these regions.
      This research report categorizes the global Somatostatin Receptor Type 2 market by top players/brands, region, type and end user. This report also studies the global Somatostatin Receptor Type 2 market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Amryt Pharma plc
      Crinetics Pharmaceuticals Inc
      Daewoong Pharmaceutical Co Ltd
      Ipsen SA
      Progenics Pharmaceuticals Inc
      Strongbridge Biopharma plc
      Zucara Therapeutics Inc

      Market size by Product
      CRN-00808
      Lanreotide Acetate
      PRL-2903
      Others
      Market size by End User
      Hormonal Disorder
      Oncology
      Metabolic Disorder
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Somatostatin Receptor Type 2 market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Somatostatin Receptor Type 2 market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Somatostatin Receptor Type 2 companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Somatostatin Receptor Type 2 submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Somatostatin Receptor Type 2 are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Somatostatin Receptor Type 2 market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now